Proceedings: Prevention by Ca-antagonistic compounds (verapamil, D 600) of coronary smooth muscle contractures due to treatment with cardiac glycosides.

Fleckenstein, A

Proceedings: Prevention by Ca-antagonistic compounds (verapamil, D 600) of coronary smooth muscle contractures due to treatment with cardiac glycosides. [electronic resource] - Naunyn-Schmiedeberg's archives of pharmacology 1974 - suppl 282:R20 p. digital

Publication Type: Journal Article

0028-1298


Animals
Caffeine--pharmacology
Calcium--antagonists & inhibitors
Cardiac Glycosides--antagonists & inhibitors
Coronary Vessels--drug effects
Dipyridamole--pharmacology
In Vitro Techniques
Muscle Contraction--drug effects
Muscle, Smooth--drug effects
Prenylamine--pharmacology
Theophylline--pharmacology
Verapamil--pharmacology